The importance of in-vitro susceptibility testing in the management of compromised hosts

Journal of Chemotherapy

Volumn 9, Issue SUPPL. 1, 1997, Pages 116-122

  Venditti, M ^a,b   Martino, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Antimicrobial susceptibility testing; Empiric antibiotic treatment; Granulocytopenia; Immunocompromised host

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; AZLOCILLIN; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFAMANDOLE; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; NORFLOXACIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; GRANULOCYTOPENIA; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION;

AGRANULOCYTOSIS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL SENSITIVITY TESTS;

EID: 0030790765     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Klastersky I, Zinner SH, Calandra T, et al, and the EORTC International Antimicrobial Cooperative Group. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988; 24: S35-S45.
2. Serra P, Santini C, Venditti M, Mandelli F, Martino P. Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic nalignancies. Infection 1985; 13: S115-S123.
3. EORTC International Antimicrobial Therapy Cooperative Group. Single daily closing of amikacin and ceftriaxone is as efficacious and no more toxic than multiple daily dosing of amikacin and ceftazidime. Ann Intern Med 1993; 115: 584-593
4. Young LS. Significance of in vitro tests. In: Combination Antibiotic Therapy in the Compromised Host, (Klastersky J, Staquet MJ, eds), Raven Press, New York, 1982: 1-15.
5. Klastersky J, Vamecq G. Cappel R, Swings G, Vandeborre L. Effect of combination of gentamicin and carbenicillin on the bactericidal activity of serum. J Infect Dis 1972; 125: 183-186.
6. Klastersky J, Cappel R, Daneau D. Clinical significance of in vitro synergism between antibiotics in Gram-negative infections. Antimicrob Agents Chemother 1972; 2: 470-475.
7. Klastersky J, Daneau D, Swings G, Weerts D. Antibacterial activity in serum and urine as therapeutic guide in bacterial infections. J Infect Dis 1974; 129: 187-193.
8. Anderson MT, Young LS, Hewitt WL. Antimicrobial synergism in the therapy of Gram-negative rod bacteremia. Chemotherapy 1978; 24: 45-54.
9. Martino P, Venditti M, Valente B, Mandelli F, Serra P. Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with Gram-negative septicemia. Eur J Cancer Clin Oncol 1985; 21: 439-445.
10. Klastersky J, Meunier-Carpentier F, Prevost JM, Staquet M. Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum. J Infect Dis 1976; 134: 271-276.
11. Serra P, Venditti M, Santini C, Martino P. Bactericidal activity of human serum after administration of azlocillin and amikacin alone and in combination against multiply resistant strains of Pseudomonas aeruginosa. Proceedings of the 13th International Congress of Chemotherapy 1983; 54: 7-12.
12. de Jongh CR, Joshi JH, Newman KA, et al. Antibiotic synergism and response in Gram-negative bacteremia in granulocytopenic cancer patients. Am J Med 1986; 80: 96-100.
13. Martino P, Micozzi A. Controversies in the therapy of fever in neutropenic patients. Curr Opinion Infect Dis 1995; 8: 415-419.
14. Sculier JP, Klastersky J. Significance ot serum bactericidal activity in Gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med 1984; 76: 429-435.
15. Martino P, Venditti M, Papa G, Orefici G, Serra P. Water supply as a source of Pseudomonas aeruginosa in a hospital for hematologic malignancies. Boll 1st Sier Mil 1985; 64: 109-114.
16. Venditti M, Santini C, Serra P, Martino P. New fluorinated quinolones and other antibiotics against coagulase negative Staphylcoccus blood isolates from neutropenic patients: in vitro comparative activity and slime production. Antimicrob Agents Chemother 1989; 33: 209-211.
17. Venditti M, Baiocchi P, Brandimarte C, et al. High rate of oxacillin resistant Staphylococcus aureus isolates in an Italian university hospital. J Chemother 1994; 6: 25-28.
18. Baiocchi P, Capone A, Carfagna P, Santini C, Venditti M. Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary care university hospital. Intern J Antimicrob Agents 1996; 7: 93-96.
19. Brunet F, Vedel G, Dreyfus F, et al. Failure to teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur J Clin Microbiol Infect Dis 1990; 9: 145-147.
20. Menichetti F, Martino P, Bucaneve G, et al. Effects of teicoplanin and those of vancomycin m initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Antimicrob Agents Chemother 1994; 38: 2041-2046.
21. Garrison MW, Anderson DE, Campbell DM, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother 1996; 40: 2859-2864.
22. Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xantbomonas] maltophilia: a prospective, multicenter study of 91 episodes. Clin Intect Dis 1996; 22: 508-512.
23. Venditti M, Tarasi A, Visco Comandini U, et al. Enterococcal septicemia in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1993; 12: 241-247.